| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 30, 2026 | Option exercise(M) | 4K | — | $0 | 119K |
| Jul 30, 2026 | Option exercise(M) | 3K | — | $0 | 122K |
| Jul 30, 2026 | Option exercise(M) | 4K | — | $0 | 125K |
| Jul 30, 2026 | Sell(S) | 4K | $23.38 | $90K | 121K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 30, 2026 | Option exercise(M) | 4K | — | $0 | 11K |
| Jul 30, 2026 | Option exercise(M) | 3K | — | $0 | 20K |
| Jul 30, 2026 | Option exercise(M) | 4K | — | $0 | 39K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001817160-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Nurix Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.